Profund Advisors LLC Senseonics Holdings, Inc. Transaction History

Profund Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.96 - $1.34 $399 - $557	416 Added 3.83%	11,283 $11,000
Q3 2022 Nov 04, 2022	BUY	$1.02 - $2.23 $11,084 - $24,233	10,867 New	10,867 $14,000
Q2 2022 Aug 01, 2022	SELL	$0.94 - $1.94 $12,015 - $24,797	-12,782 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.54 - $3.71 $2,836 - $6,833	-1,842 Reduced 12.6%	12,782 $25,000
Q4 2021 Feb 08, 2022	BUY	$2.58 - $3.91 $5,100 - $7,730	1,977 Added 15.63%	14,624 $39,000
Q3 2021 Nov 12, 2021	BUY	$2.77 - $4.05 $1,246 - $1,822	450 Added 3.69%	12,647 $43,000
Q2 2021 Aug 12, 2021	BUY	$1.71 - $4.14 $20,856 - $50,495	12,197 New	12,197 $47,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.